Gue, Ying X.
Kanji, Rahim
Wellsted, David M.
Srinivasan, Manivannan
Wyatt, Solange
Gorog, Diana A. http://orcid.org/0000-0002-9286-1451
Funding for this research was provided by:
Bayer (IIR-GB-2017-4575)
Article History
First Online: 23 December 2019
Compliance with ethical standards
:
: The study is funded by Bayer PLC (Grant No. IIR-GB-2017-4575). Bayer Plc have had no input into the trial design or the writing of this manuscript. DAG has received travel grants from Bayer Plc, and institutional research grants from Bayer PLC and Bristol Myer Squibb. DAG is related to a company director in Thromboquest Ltd. which manufactures the GTT, but neither she, nor her spouse or children have financial involvement or equity interest in, or received financial assistance, support or grants from the aforementioned company and the aforementioned company will have no involvement in the design, conduct or the finance of this research study. Consumables will be purchased as normal commercial transactions without the manufacturer giving any financial support. There are no other contracts, benefits or personal relationships to disclose.